[Review and guidelines for treatment of diarrhea caused by Vibrio parahaemolyticus].
In Chile Vibrio parahaemolyticus has been detected in 3 gastroenteritis outbreaks since 1998. The most recent outbreak occurred during the summer of 2005, affecting over 10,000 people of whom one died. Affected individuals presented with one or more of the following symptoms: diarrhea, nausea, vomiting, abdominal pain and/or fever. Fecal white blood cells were detected in only 6% of patients. The predominant serotype in the 3 outbreaks was the pandemic O3:K6 strain. Diagnosis was confirmed by isolation and identification of V. parahaemolyticus in stool cultures and/or by establishing an epidemiological link. V. parahaemolyticus isolates were 100% susceptible to tetracycline, ciprofloxacin and chloramphenicol, and universally resistant to ampicillin. Due to the public health impact of the 2005 outbreak, the Ministry of Health called for a National Task Force mandated to review epidemiological, clinical and microbiological features of the outbreak and to propose management guidelines.
Heitmann
Ingrid
I
Departamento de Epidemiología, Ministerio de Salud, Chile.
Jofré
Leonor
L
Hormázabal
J Carlos
JC
Olea
Andrea
A
Vallebuona
Clelia
C
Valdés
Claudio
C
D000293:Adolescent; D000328:Adult; D000368:Aged; D000818:Animals; D002677:Chile / Q000453:epidemiology; D003967:Diarrhea / Q000453:epidemiology / Q000382:microbiology / Q000628:therapy; D004196:Disease Outbreaks; D005243:Feces / Q000382:microbiology; D005260:Female; D005759:Gastroenteritis / Q000188:drug therapy / Q000453:epidemiology / Q000382:microbiology; D006801:Humans; D008297:Male; D008875:Middle Aged; D012703:Serotyping; D012720:Severity of Illness Index; D014735:Vibrio Infections / Q000453:epidemiology / Q000382:microbiology / Q000628:therapy; D014736:Vibrio parahaemolyticus / Q000145:classification